Cell-Based Models for Development of Antiatherosclerotic Therapies

Emile R Zakiev1, Nikita G Nikiforov2, Alexander N Orekhov3

  • 1Institute of General Pathology and Pathophysiology, Moscow, Russia; INSERM UMR_S 1166-ICAN Faculté de Médecine Pitié-Salpêtrière, Paris, France.

Insights

Cardiovascular disease, a leading cause of death, involves arterial plaque buildup. This review highlights cell models for screening potential atherosclerosis treatments, offering hope for clinical applications.

Area of Science:

  • Biomedical research
  • Cardiovascular science
  • Cell biology

Background:

  • Cardiovascular disease is a global health crisis, primarily driven by atherosclerosis.
  • Atherosclerotic plaque development is often asymptomatic until advanced stages, limiting early intervention.
  • Current treatments for atherosclerosis have questionable efficacy and safety profiles.

Purpose of the Study:

  • To review the utility of in vitro and ex vivo cell models for studying atherosclerosis.
  • To identify models suitable for screening novel therapeutic compounds.
  • To explore the potential of cell models for advancing clinical applications in cardiovascular disease.

Main Methods:

  • Literature review of studies utilizing cell-based models for atherosclerosis research.
  • Analysis of in vitro models (e.g., cell cultures) and ex vivo models (e.g., tissue explants).
  • Evaluation of model relevance for assessing plaque development and regression.

Main Results:

  • Cell models offer a viable platform for investigating the mechanisms of atherosclerosis.
  • These models facilitate the screening of compounds for anti-atherosclerotic properties.
  • Successful application of cell models can accelerate the development of effective treatments.

Conclusions:

  • In vitro and ex vivo cell models are crucial tools for cardiovascular research.
  • These models provide a promising avenue for discovering and testing new therapies for atherosclerosis.
  • Advancements in cell modeling can significantly impact clinical strategies for managing cardiovascular disease.